Vera Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Vera Therapeutics, Inc. (VERA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are VERA insiders buying or selling?
In the last 12 months, Vera Therapeutics, Inc. insiders reported 1 open-market purchase ($250.0K) and 21 sales ($12.3M) — net selling of $12.1M. Since May 2021, Trabud has recorded 102 Form 4 filings for VERA: 34 buys ($115.3M) and 68 sells ($89.0M).
Source: SEC EDGAR Form 4
Key Statistics (May 2021 – Sep 17, 2026)
Total Form 4 filings
102
SEC EDGAR
Insider filers
19
Insider buys (34)
$115.3M
Insider sells (68)
$89.0M
Insider sentiment
Net buyingNet insider flow of $26.3M in net buying since May 2021, and $12.1M in net selling over the last 12 months.
Recent VERA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 18.5K | $37.00 | $684.5K | SEC ↗ |
| Sep 4, 2026 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 18.5K | $35.12 | $649.6K | SEC ↗ |
| Aug 12, 2026 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 46.3K | $42.30 | $2.0M | SEC ↗ |
| Aug 12, 2026 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 18.5K | $37.93 | $701.8K | SEC ↗ |
| Aug 12, 2026 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 18.5K | $36.74 | $679.7K | SEC ↗ |
| Jul 9, 2026 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 46.3K | $42.30 | $2.0M | SEC ↗ |
| Jun 24, 2026 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 18.5K | $37.93 | $701.8K | SEC ↗ |
| May 13, 2026 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 18.5K | $36.74 | $679.7K | SEC ↗ |
| Apr 15, 2026 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 23.0K | $44.05 | $1.0M | SEC ↗ |
| Feb 26, 2026 | Robert Brenner | Chief Medical Officer | Sale | 2.2K | $41.98 | $90.3K | SEC ↗ |
| Feb 26, 2026 | Joseph R Young | SVP, FINANCE, CHIEF ACCT OFFCR | Sale | 3.1K | $41.98 | $130.9K | SEC ↗ |
| Feb 26, 2026 | Sean Grant | CHIEF FINANCIAL OFFICER | Sale | 4.9K | $41.98 | $207.8K | SEC ↗ |
| Feb 26, 2026 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 16.9K | $41.98 | $710.6K | SEC ↗ |
| Feb 26, 2026 | David Lee Johnson | Chief Operating Officer | Sale | 2.6K | $41.98 | $108.3K | SEC ↗ |
| Feb 26, 2026 | William D. Turner | Chief Regulatory Officer | Sale | 2.2K | $41.98 | $91.8K | SEC ↗ |
| Feb 26, 2026 | Laurence Matthew Skelton | Chief Commercial Officer | Sale | 1.6K | $41.98 | $66.4K | SEC ↗ |
| Dec 17, 2025 | William D. Turner | Chief Regulatory Officer | Sale | 10.0K | $50.08 | $500.8K | SEC ↗ |
| Dec 16, 2025 | Patrick G Enright | Director | Purchase | 5.9K | $42.50 | $250.0K | SEC ↗ |
| Dec 10, 2025 | William D. Turner | Chief Regulatory Officer | Sale | 10.0K | $45.31 | $453.1K | SEC ↗ |
| Dec 4, 2025 | William D. Turner | Chief Regulatory Officer | Sale | 10.0K | $40.00 | $400.0K | SEC ↗ |
| Nov 25, 2025 | Jason S Carter | Chief Legal Officer | Sale | 3.9K | $27.82 | $107.5K | SEC ↗ |
| Nov 14, 2025 | Joseph R Young | SVP, FINANCE, CHIEF ACCT OFFCR | Sale | 15.0K | $29.06 | $435.9K | SEC ↗ |
| Jun 26, 2025 | Patrick G Enright | Director | Purchase | 250.0K | $21.11 | $5.3M | SEC ↗ |
| Feb 27, 2025 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 19.7K | $27.78 | $546.9K | SEC ↗ |
| Jan 10, 2025 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 17.5K | $41.74 | $730.5K | SEC ↗ |
Showing the 25 most recent of 102 Form 4 filings for Vera Therapeutics, Inc..
Most active VERA insiders
- Marshall Fordyce30 filings
- Joanne Curley18 filings
- Beth C Seidenberg14 filings
- Joseph R Young6 filings
- Sean Grant6 filings
Ask anything about VERA insider activity
Use Trabud's AI agent to query Vera Therapeutics, Inc.'s Form 4 history in plain English — "Show me VERA CEO purchases this year" or compare it against any other ticker.
Open the AI agentVERA insider trading FAQ
Are Vera Therapeutics, Inc. insiders buying or selling?
In the last 12 months, Vera Therapeutics, Inc. insiders reported 1 open-market purchase ($250.0K) and 21 sales ($12.3M) — net selling of $12.1M. Since May 2021, Trabud has recorded 102 Form 4 filings for VERA: 34 buys ($115.3M) and 68 sells ($89.0M). Over the full record that is net buying of $26.3M.
How many insiders trade VERA stock?
19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Vera Therapeutics, Inc.. The most recent filing was accepted on Sep 17, 2026.
Where does Trabud get VERA insider trading data?
All VERA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.